The ultimate success orfailure offro ntal sinus surg ical procedures, wliether they be endonasal al' external, is detennined essentially by the rat e of res tenosis of the froutal sinus outflo w tra ct OI' neo -osti utn postop erat ively.
Introduction
Endonasal treatment of front al sinus inflammatory d isease has becom e increasingly established during the past few yea rs.J-14 Th e ultimate success OI' fa ilure of fro ntal sinus surg ical procedures, whether they be endonasal OI' ex ternal, is dete rmined ess entially by the rate ofresten osis of the front al sinus Ola flow tract (FSOT) OI' the neoostium po stoperatively. The spectru m of endonasal pro-cedures inel udes ( I) exposure of the frontal rece ss with preservati on of the nat ural ostium, (2) resectio n of the frontal sinus f1 00r betw een the lamina pap yracea and the nasal septum, and (3) med ian drainage with rem oval of the fro ntal sinus f1 00r on both sides and removal of adjacent parts of the interfront al and nasal septum, e1 assified as Draf types I, II, and III (table 1). 2.4.13.15.16 In about o ne-t hird of cases whe n the fro ntal sinus is opened intraoperat ively, the passage ofa probe will not be possible after heal ing." Thi s prop orti on ca n be redu ced by performi ng an inte nsi ve intraoperative dissecti on at the frontal sinus ostium ': " OI' by cre ating a Draf type III draina ge.J31n both cases, the more extens ive procedure is repor ted to carry a lower risk of reste nosis and co nfe r a greater likelihood of muco sa l healing. Howe ver, in the case of type III drain age in parti cul ar , the surg ical trauma is not insigni ficant. T he more ex te nsive rem ov al ofbony structures with a drill leads to a more marked postoperative infla mmato ry respon se, and some health y structures (e.g., parts of the nasal septum, the interfrontal septum, the anterior att ac hment of the middle tur bi nate, and part s of the frontal pro ce ss) must be sacrificed to ac hieve wide drain age. Desp ite the creat ion of a very wide opening intraoperat ively, it can not be guarantee d that the openin g will not close co mplete ly dur ing the succeeding weeks OI' months.
Endo nasal fro nta l sinus surge ry fail s whe n the spec ific patho logy canno t be reached OI' when a long-Iasti ng stabile drainage ca nnot be established . In these cases, an ex terna l approach is necessary. T he osteo plastic f1 ap proced ure with fat obliteration has been hailed as the gold standard of definitive fro ntal sinus proced ures.' ?""
To minimi ze the surgica l trauma and scarring and to avoid larger operations, particularly the extern al approach, stenting of the FSOT and neo-ostium should be considered. Th e decisive point is that the du rat io n of stenting placem ent must be long enough so that wo und healin g and scar remodeling are nearly complete. It ha s been shown In this article, we describ e our exper ience with stenting of the FSOT and neo-ostium in difficul t cases in patient s who had had recurrent polypoid disease and major scarring at the FSOT.
Patients and methods
We retrospectively evaluated 12 pati ents who had received a frouta l sinus stent that had been placed to keep the FSOT open (table 2) . Eight of the se patients had had recurrent chro nic polypoid sinusitis wit h major involvement of the frontal sin us. Their FSOTs had been closed by scar tissue . The deci sion to introduce a fronta l sinus stent into these patients was based on the intraoperative ob servance of major area s of denud ed bone at the completion of the operation. Th e indication fo r revisionaI endonasal frontal sinus surgery was based on ther apy-resistant headache and corresponding sign s on co mputed tomography «rn Two othe r patient s had had an osteo ma of the front al sinus . After the os teo ma wa s co mplete ly removed Initial dinleal studies show that Zicarn" Cold Remedy significantly reduces the duration of the common cold when taken at the onset of symptoms, and also reduces the severity of common cold symptoms including nasal congestion, sneezing and coughing.
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Visit our website at www.zicam.eom endo nasally, the mueosa of the FSOT was also removed, and denu ded bone was see n on all sides . The re ma ini ng two pati ent s had had m ueo pyoeeles after previou s sin us surgery for maj or sea rr ing of the FSOT.
None of these patients wished to have an externa I o peratio n, and a ll ag reed to und e rgo a n endonasal re visi on and long-term ste nting of 6 months.
Typ e of pro cedure. With a mieroseope and endoseope, a wide ope ning on one or both sides of the fron tal sinus was made to estabIish a Dr af type II or III drainage.' Depending on the indiv idual situatio n, three types of stents were inserted .
One ste nt was a Rains self-retaining siIieone tube with a co mpress ible basket at the fro ntal sinus end. Th is stent was used for patient s with unilater al disease (figure I).
Th e second stent was a siIieone tube of 5 mm in diameter that was positioned in a U-shaped mann el' into both FSOTs (figure 2) . Insertion was made possi ble by ereating a sma ll perforation in the upp er part of the nasal sep tumoThi s type of proeedur e was used for patie nts who had bilater al disease in order to ac hieve op tima l positi oning of the stent and to avoid erus ting on the end of the nasal tube inside the middle meatus.
Th e third typ e of stent was a self-re taining H-shaped siIieo ne tube, whie h was used fo r proeedures that involved a type III revision (figure 3).
Postop erative management andfollowup, In all cases, the nose was paeked for 5 to 7 days wi th rubb er finger staIIs. Postoperati ve treatment inelude d a 6-month eourse of topieal steroids and self-administere d nasal irrigation with saline solutio n de livere d by a nasa I do uehe three times dai ly. Th ere was no routine admi nistra tion of antibiot ies or sys te mie eortieo ids.
Endoseopie fo IIowup exa minations with a flex ible endoseope were performed afte r removal of the stent and at the final fo IIowup visit. Th e fro ntal sinus opening was determ ined to be either ( I) ope n so that the fro ntal sin us mueosa itself eo uld be seen, (2) ope n but narrow so that the fron tal sin us mueosa eould not be assessed , (3) not visib le beeause of the prese nee of polyps or sea l' tissue in the ethmoid, or (4) closed beeau se of searr ing in the FSOT..Additionally, all patient s were asked to provide a subjeetive j udg ment of their ow n outeome aeeording to four eatego ries : ( I )free ofcomplaints or major impravement, (2) tnoderate itnpro vement, (3) mi/d or no impravement , or (4) worse. Patie nts whose fro ntal sinus eould not be eva luated en doseopieaIIy were adv ised to undergo CT or magnetie reso nanee imaging (MRI) so that aeratio n of the fro ntal sinus eo uld be evaluated.
Th e goa l of the stenti ng proeedure was to prevent the elos ure of the FSOT by seal' tissue. We co nsidered this goa l to have been aehieved if the fro ntal sinus eould be viewed endoseopieally as open or if the fron tal sinus was show n by CT or MRI to be aerated .
Results
Altogether, the 12 patie nts reee ived 2 I ste nts (tab le 3) . Seven sinuses reeeived a Rains fro ntal sinus stent (three patients unilateral, two bilateral), 10 sinuses reeeived a U- This BriefSummary is basedon the eurrent circular CI 4468-3, Issued October22, 1998. false-positivereaetion for glueose in the urine using Clinitest" : ", Benediet's solution, or Fehling's sotution. It is reeommendedthat glueose tests based on enzymatie glueose oxidase reaetions (such as Clinistix"" or Tes-Tapev" ) be used. A lalse-positive direet Coombs test has been reported during treatmentwith other eephal osporinantibioties; it shouldbe reeognized that a positive Coombstest may be due to the drug. Careinogenesis, MUlagenesis, Impairmenl 01 Ferlilily: Liletime studies in anirnals to evatuate earei nogenie potenti al have notbeen eonduet ed. SUPRAX di d not eause point mut ations in baeteria or mammalian eeil s, DNA damage, or ehromosome damage in vitro and did not exh ibit elastogenie pot ential in vivo in the mouse mieronueleus tes!. In rats, ferlility and r eproductive performance were not alfeeted by eefixime at doses up to 125 times the adult therapeutie dose. Usage in Pregnaney: Pregnaney Category B. Reprodu ction studies have been perlormed in miee and rats at doses up to 400 timesthe human dose and have revealed no evidenee 01 harm to the fetus due to SUPRAX. There are noadequate and weil-eontrolled studies in pregnantwomen. Thi s drug should be used during pregnancy onl y if clearl y needed. Labor and Delivery: SUPRAX has not been studied lor use during labor and del ivery.Gi ve onl y if elearly need ed. Nursing Molhers: It is not known whetherSUPRAX is exereted in humanmilk. Consider diseontinuing nursing temporaril y during treatmant . Pediatrie Use: Safety and effeeti veness of SUPRAX in ehildren aged iess thansix months old have not been estabiished. The incidenee 01Gl adversereaetions, ineluding diarrhea and loose steots. in pedi atrie pati ent s reeeiving the suspension. was eomparableto the incidenee seen in adult patient s reeei vingtabl ets.
ADVERSE REACTIONS:
Most adverse reaetions observed in elinieal triai s wereof a mild andtransientnat ure. Fi ve pereentof pati ents in theU.S.trlal s diseontinued therapybeeause 01drug-rel ated adverse reaetions. The most common adverse reaetions in U.S. trials of the tablet formul ation were Gl eve nts, whieh were reporled in 30% of adult patients on either the BID or the OO regimen. Clinieall y mild Gl side effeets oeeurred in 20%01 all patients, moderate events in 9%, and seve re adverse reaetions oeeurred in 2% 01 ail pati ents. Indi vidual event rates included diarrhea 16%, loose Dr frequentstools 6%, abdominal pain 3%, nausea 7%, dyspepsia 3%, and Ilatul enee 4%. The incidenee 01 Gl adverse reaetions, ineluding diarrhea and loose stoois, in pediatrie patient s reeeiving the suspensi on was eomparabl e to that seen in adult patients reeeiving tablets. Symptoms usually respond ed to symptomatie therapy or eease d when SUPRAX was diseontinued. Seve ral patients developed severe diarrhea and/or doeum ent ed pseudom embr anous eoiitis, and a lew requiredhospitali zati on.
The loilowing adverse reaetions have been reported loliowing the use 01 SUPRAX. Incidenee rates were less than 1 in 50 (Iess than 2'10), exeept as noted above for Gl In addition to the adverse reactions listed above whieh have been observed in patients treated with SUPRAX, the loilowing adversereaetions and altered laboratory tests have been reportedfor cephalosporin-class antibioties: Adverse Reaetions: Ail ergie reaetions ineluding anaphyiaxis, toxie epidermai neerolysis, super inleetion, renai dyslunetion , toxie nephropathy, hepatie dysluneti on ineluding eholestasis, aplastieanemia,hemoly1ie anemia, hemorrhage, and eolitis. Appropriate cultures and suseepfibiiity studies should be perlorme d to determine the eausative organism and its suseeptibility to SUPRAX; however , therapy may bestartee whileawaitingthe resul ts 01thesestudies. Therapy should beadjusted, if neeessary, onee these results are known.
"Effieaey for fhis organism in this organ system was studied in lewerthan10 inleetions.
CONTRAINOICATIONS:
In pati ent s with known ailergy to theeephalospori n group of antibioties. Administerantibiotics, ineiuding SUPRAX, eautiously to any pati entwho has demonstrated some form 01ailergy, particul arly to drugs. Treatmentwith broad-spectrurn antibioties, ineluding SU PRAX, alters the normal Ilora 01 the eolon and may permit overgrowth of elostrlola. Studies indieate that a toxin produeed by Cl ostridium diffieile is a primary eause of severeantiblotic-associated diarrhea ineluding pseudomembranous eolitis.
WARNINGS
Pseudomembranous eolifis has been report ed with the use of SUPRAX and other broadspeetrum antibioties(ineluding maerolides, semisynthetie penieillins, and eephalosporins); therefore, it is important to eonsider this diagnosis in patient s who devel op diarrhea in association wifh the use 01 antibioties. Sym ptoms 01 pse udomembranous eoiitis may oeeur during or after antibiotie treatment and may range in seve rity from mild to lilethreatening. Mild cases 01pseudomembranous eolitis usuall y respond to drug dlscontlnuation alone. In moderate to severe cases, managementshould include Iluids, eleetroly1es, and protein suppiementation. II the eoiitis does not impreve after the drug has been diseontinued , or il the symptoms are severe, orai vaneomyein is the drug 01 choicelor antibioti e-assoeiated pseudomembranous eolitis produeed by C. diffieil e. Other eauses of eolilis should be exeluded. Table 3 . Fro ntal sinus surge ry: Typ e of drainag e (Draf classifi cat ions-v "), type of stent, and o pe rat ed si de shaped stent (five pati ent s bilater al), and four reeei ved an H-shaped stent (two patients bilateral). All ste nts were removed after 6 months.
After a followup of lOt o 36 month s (mean: 19.4), 10 of the 12 patients reported that they were either free of eomplaints al' that they had experi eneed major impravement (table 4) . The remaining two patients judged their impravem ent to be moderate.
The two patients who had had an osteo ma with otherwise healthy mueo sa reta ined their normal mueosa and did not experience any polyp dev elopment. Bot h of their FSOTs were wide open.
All eight patients who had had polypoid sinusitis preoperative ly ex perieneed a ree urre nee of polyps during foll owup. Three of the se patient s ex perieneed so me superimposition of ede ma as a res ult of ae ute vi ra l rhin osinusiti s.
Two of the thre e type III drain ages were not vis ible on endoseopy beeause of polyps in the ethmo id (table 4). One of these two patient s agreed to an MRI examination , whi eh showed that the frantal sinus was ae rated and that the type III drainage was ope n.
Of the rem ainin g 15 FSOTs (type II draina ge), nine were not visible on endoseo py beeause of the presenee of ethmoidal polyp s. Five were later examined by CT a l' MRI , and four were not. All five FSOT s that underwent follow up radiologie evaluation were found to be vent ilated ( figure 4) 5) . Th e small perforati on in the upp er part of the nasal se ptum that was made during the U-shaped stent procedu re remai ned in all five of these patient s, but it eause d no sy mpto ms.
All in all , surgery and stenting eo uld not prevent the reeurrenee of local polyp oid sinusitis. Howeve r, it did prevent functional, relevant stenos is of the FSOT by seal' tissue in 15 of the 21 sinuses . For the remainin g six sinuses, endos copic evaluation was hind ered by ethmoidal polyps and CT or MRI examinatio n was not avail able. Therefore, a definitive assessment of the se patie nts was not pos sibl e. Neverthe less, they were all free of eomplaints.
D iscuss ion
Our study shows that long-t erm stenting of the FSOT was able to prevent restenosis by scar tissue in a large number of very difficult revision cases. Sten ting cou1dnot prevent a recurrence of the local regrawth of polyp s, but it did aeeomplish at least partial drain age and ventilation. Thi s led to a maj or impraveme nt of patient s' sy mptoms and help ed them avoid major external surger y.
Th e redu eti on in postoperati ve sy nec hiae and stenosis is regard ed as the deci sive advantage of ste nts. Acco rdin g to a literature review by Shikani , sea rring oeeurs in 6 to 15% of cases, and the blockage of the middle meatu s leads to a reeurrenee of sinusitis in up to 7%.21Toffel described his experience in treating mare than 3,000 patient s." He insert ed a speeial silieone and Meraeel paek for 5 to 7 da ys und er cephalosporin antibiotic cover following combined endoseopic parunusal sinus surge ry and septoplas ty. A second Meracel sponge was placed in the inferior nasa l eavity for gentle compressia n of the sep tum , and a ventilatian tub e was also inserted. Of the 1,363 patients he follo wed , only 4 1 (3%) de velop ed synec hiae between the middle turb inate and lateral wall I to 3 years postoperatively. Rev ision surge ry was necessary in only 15 cases.
With tion tub e that was ane hored to the anter ior nasal se ptum with a Vier yl suture." Th e indi eati on s for thi s pro eedure were aeute or ehr on ie fro ntal sinus itis in pati ent s who had und ergon e at least one previou s ope ratio n and who had had marked frontal sinus path olo gy on CT. Th irty-two tube s were inserted in 21 pati ent s and left in place for an avera ge of 8.3 week s. Aft er an unspeeified but short follo wup, the failure rate was 9.5% . In a pro spective study by Weber et al, 80% of the frontal sinus neo-osti a were endoseopiea lly ope n 12 to 16 months after long-term ste nting, co mpared with only 33 % of fro ntal sinuses th at we re not stented." Oeclusion by sear tissue was see n in 6.7 and 48% of the two gro ups, res pec tive ly . Wi gand and Hosemann fo und that 3.5 years after sphe noe thmoideetomy and enlarge me nt of the frontal infundibulum wit h a diamond burr (n =126 sides), the fro nta l sinus was endoseopiea lly aeeessible in 40 % ; probing was possibl e in 30 % and not possibl e in 30 %.14 Hosemann et al fo und an endoseopieally aecessible fro ntal sinus in 22 % of 154 operations an ave rag e of 13 month s followi ng endoscopie extended frontal sinus drainage; probing was possibl e in ano ther 59 %.9 On the basis of preei se intra -and posto pe ra tive me asurem ent s, Hosem ann et al found a deerease in the ave rage minimum diameter from 5.6 mm intr aoper atively to 3.5 mm postoperatively. Below an intraoperative minimum diameter of 5 mm, the proportion of ostia that beeame ob strueted 938 postoperati vely ro se sha rply, fro m 16 to more than 30 %.
As a pro cess of the ph ysiologic mechanisms that are inv ol ved in both po stoperative wound healing in ge nera F 8 .~9 and wound healin g aft er paranasal sinus surgery":" restenosis of a surgica lly enlarged opening of the frontal sinu s ean tak e place in three partly related ways .
First, restenosis ean oceur as a res ult of a persistent ob stru etion of the opening by blood and fib rin during the immediate postoperative phase. During the proliferativ e phase beginning on postoperat ive day 2 or 3, fibroblasts migrate into the fibrin mesh and fo rm granulation tissue. Coll agen is depo sited and the ope ning ea n beeom e oeelu ded by sea r tiss ue .
Second , the mark ed swelling tha t begin s during postoperat ive week Y I.3~ea n lead to the fo rma tion of eon tact zo nes bet ween adjaeent or op posi te parts of the front al si nus ope ning . As a res ult of either a prim ary abse nee of epithe lializa tion or secondary ep ithe lia l dam age ea use d by pressure-in duee d macerati on or infla mmatory eelis, eo ntae t bet ween are as of gra nulation tissue ea n lead to the for mation of tissue br idges. Here, too , the final stage is occl usion by sear tissue.
Third, stenos is ea n oec ur as aresult of the reali gnment of coll agen fibe rs during the rem od elin g ph ase that begins during postoperati ve we ek 3. In this ea se, the fibers form "scar leafl ets" on concave surfaces because the distanee ean be sho rtened on ly by mak ing use of the free lumen. Thi s can lead to a co ncentric narrowing of ring-sh ap ed ope nings. T he insertion of a ste nt aIlows e pithe lia liza tio n to tak e place alo ng the surface of the device. Th e presence of a ste nt pro vide s the subepithe lial sc ar layer a chanee to sta bilize . T o be effe ctive, a stent mu st the refore rem ain in situ for several months. Six months appears to be appropri ate and sufficie nt. Good results hav e be en achie ved in tracheal surgery with the inserti on of M ont gornery tub es, which are also left in place for several month s, Resten osi s is conside ra bly less Iikel y to occ ur whe n a ste nt is left in place for 6 months than whe n it is re moved after only 2 OI' 3 we eks.
ENT-Ear
Certainly, there are some problern s with the use of 9 40 frontal sinus ste nts . If the stent is too short, gr anul ati on s ca n ove rgrow it and ernb ed it in sca r tissu e. If the ste nt is too lon g, a persi stent crus ting of the nasal end wiIl occur, which can disturb the patient and ca n ca use an unpleasant sme ll. As piratio n ca n al so occur, although ade quate fixation of the ste nt should pre vent this. O n the ot her hand, the se lf-anc ho ring de sign of some mod em stents obviates the risk of disloc ati on . Th e tran sse ptal inserti on of a U-shaped stent is an optio n for spec ial revision cases in patients who have lar ge wo und areas insid e the eth moi d cavity and a fro ntal sinus that need s to be splinted. 
